Laxatives: Supply issues
There are supply issues affecting a number of laxatives.
14 September 2022: Glycerol (Lax-suppositories Glycerol) Suppos 4 g supply issue resolved
There are known supply issues with Laxsol (docusate sodium with sennosides) and bisacodyl. This is having a knock on effect with other funded laxatives. We are working closely with all suppliers concerned to speed up freight to Aotearoa where possible.
Please order normally. This allows the available product to be distributed as fairly as possible.
Dulcolax SP Drop
There has been a brief out of stock of Dulcolax SP Drops. Stock has arrived in Australia and is undergoing quality assurance review. Stock will then be air freighted to New Zealand, we anticipate this will be the week ending 9 September. It will take time for this stock to make its way through the supply chain to individual pharmacies.
The Laxsol supply issue was caused by a lack some of the raw materials used to make the product. This issue also affects Coloxyl.
Shipments are being released as they arrive. We're working closely with the supplier to understand when Laxsol supplies will return to normal. Both the supplier and Pharmac are aware of the critical nature of this product.
Supplies of bisacodyl have resumed with the new supplier, Viatris.
Docusate sodium (Coloxyl) 50 and 120 mg tablets resupplied
The supply issue with Coloxyl 120 mg is now resolved. Supplies of the 50 mg remain constrained. Next shipment due early September.
Glycerol (Lax-suppositories Glycerol) Suppos 4 g resupplied
Lax-suppositories Glycerol (Pharmacode 2637103) were listed from 1 September 2022 to replace the PSM brand product. Stock of the new brand is now available to order.
PSM brand glycerol suppositories will remain listed until 1 February 2023, but stock may be limited.
Konsyl-D and psyllium husk
Konsyl-D and the alternative we listed (psyllium husk) are out of stock. Viatris, anticipates the psyllium husk will be available again by mid-September 2022. Resupply date for Konsyl-D remains October 2022.
Due to high demand, driven by shortages of other products, senna is out of stock with the supplier. Supply is expected to arrive in New Zealand by the end of August. We are still awaiting confirmation from the supplier that the shipment has arrived.
Sodium citrate with sodium lauryl sulphoacetate (Micolette) enema
Stocks of Micolette are low. New stock is arriving in August. It is listed as section 29 because there was a change in manufacturer and this change hasn't yet received Medsafe approval. We've listed the section 29 product to ensure continuity of supply. Registered stock is expected by early October 2022.
This is a global issue
These supply challenges are not unique to Aotearoa or to healthcare – they are being felt across the world and across almost every sector. We know it can be tough, with everyone facing disruptions due to the supply chain. It’s especially difficult when it is unexpected.
We want to reassure New Zealanders that Pharmac is working as hard as possible to ensure everyone has access to the medicines and devices they need to support their health and wellbeing.